1.2 billion Asians will join the middle class by 2030, fuelling the demand for quality healthcare services. Healthcare in Asia will be a USD3 trillion+ market by 2030. Its scale (Asia/ China’s scale), the digital leapfrog and silver economy offer complimentary opportunities in this sector. It is estimated that 70% of global healthcare growth (2025-2030) will come from Asia. The medical & healthcare sector became one of the Group’s core focus industries since 2018, with our investment to the merger of the largest Hong Kong fertility group Women’s Clinic Group and acquisition of 3rd largest Australia fertility group Genea.
We believe that the rising income of Greater China and Asia will drastically increase the demand for quality healthcare including healthcare services for the silver economy. Our investment in fertility services benefits from the many advanced cities face population aging problems.
